Stephan Dietrich A, President & CEO, Director, Ten Percent Owner at NeuBase Therapeutics, holds 2.56M shares in NeuBase Therapeutics (Ticker: NBSE). Most recently, Stephan Dietrich A Bought $1,275 shares of NeuBase Therapeutics on Jun 10, 2020 for an estimated value of 9.86K.